125,000,000 Principal Amount (Includes Exercise of Over-allotment Option In Full) 4 1/4% CONVERTIBLE SUBORDINATED NOTES DUE 2008 CROSS-REFERENCE TABLE*Axcan Pharma Inc • April 2nd, 2003 • Wholesale-drugs, proprietaries & druggists' sundries • New York
Company FiledApril 2nd, 2003 Industry Jurisdiction
DEBT SECURITIES (TITLE OF THE INDENTURE SECURITIES)Axcan Pharma Inc • April 2nd, 2003 • Wholesale-drugs, proprietaries & druggists' sundries
Company FiledApril 2nd, 2003 Industry